Megarest 5mg Injection
By Megarest
Rx
5ml Injection in a Vial

Composition
Midazolam(5mg)

Manufacturer - Vhb Life Sciences Inc
50-AB, Government Industrial Estate, Charkop Naka, Kandivali West , Mumbai - 400067, Maharashtra, India

Expires on or after
September, 2025

liver
There is limited information available regarding the use of Megarest 5mg Injection in patients with liver disease. It is important to consult your doctor for guidance on the safety and potential risks associated with using this injection if you have liver issues. It is recommended to seek medical advice before taking Megarest 5mg Injection if you have any liver concerns.

kidney
Use Megarest 5mg Injection carefully if you have severe kidney disease. Your doctor may need to adjust the dosage. Always seek advice from your doctor before using this medication.

alcohol
When consuming alcohol with Megarest 5mg Injection, excessive drowsiness may occur. It's important to be cautious of this interaction for your safety.

driving
Caution should be taken when driving after using Megarest 5mg Injection as it may cause drowsiness, forgetfulness, and impact concentration and coordination, potentially impairing driving ability.

pregnancy
Megarest 5mg Injection should not be used during pregnancy due to the risk to the developing baby. In life-threatening situations, a doctor may prescribe it only if the benefits outweigh the risks. Consult your doctor for advice.

breastfeeding
Megarest 5mg Injection is considered safe during breastfeeding based on limited human data. It is advised to use for short periods, monitor baby's sleepiness, and withdraw gradually.
Habit Forming | Yes |
Chemical Class | Benzodiazepines Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Benzodiazepines |
₹36
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024